Core Viewpoint - Lumexa Imaging Holdings is set to raise $463 million by issuing 25 million shares at a price of $18.50 each, with a market capitalization of $1.8 billion post-listing [1] Company Overview - Lumexa Imaging Holdings is a national provider of outpatient diagnostic imaging services in the United States, operating 184 imaging centers across 13 states through wholly-owned sites and joint ventures with healthcare systems [1] - The company offers a range of advanced and routine imaging equipment, including MRI, CT, PET scans, X-rays, ultrasounds, and mammography [1] Financial Projections - For the 12 months ending September 30, 2025, Lumexa is projected to achieve sales of $1 billion [1] Listing Details - The company plans to list on NASDAQ under the ticker symbol "LMRI" [1] - The joint bookrunners for this offering include Barclays, JPMorgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James [1]
Lumexa Imaging(LMRI.US)IPO定价18.50美元，拟筹资4.63亿美元